Gastroenterology

Novel Treatment for Ulcerative Colitis Improves Compliance

Novel Treatment for Ulcerative Colitis Improves Compliance – MM1503

Ulcerative Colitis is a form of inflammatory bowel disease producing inflammation and ulcers along the inside of the colon, which can interfere with the normal function of the colon, often causing cramping, bloating, diarrhoea, bleeding, fatigue, weight loss and frequent bowel movements, which may also strongly affect quality of life. The 2011 reported incidence of ulcerative colitis was 1.2 to 20.3 cases per 100 000 persons per year with a prevalence of 7.6 to 246 cases per 100 000 per year.

Modern Medicine – March 2015

March 31, 2015 by Gastroenterology Ulcerative Colitis

Human Intestinal Microbiome Changes Over Time

Human Intestinal Microbiome Changes Over Time – MM1501

Recent developments in next generation sequencing (NGS) methods have facilitated the performance of metagenomic studies to determine gut microbiome composition. These methods, together with the use of gnotobiotic animals have demonstrated the importance of the microbiota for host health, providing the basis for the use of dietary interventions aimed at counteracting microbiota aberrancies.

Modern Medicine – January 2015

January 27, 2015 by Gastroenterology Probiotics

Small Bowel Video Capsule Endoscopy

Small Bowel Video Capsule Endoscopy – MM1410

Video capsule endoscopy (VCE) is an important and useful tool in assessing the small intestine. Its main indication is in patients with recurrent and/or persistent bleeding in the small bowel for which no source has been found on gastroscopy and colonoscopy. VCE is the most sensitive and specific non-invasive test available for detecting mucosal changes in the small bowel.

Modern Medicine – October 2014

October 28, 2014 by Endoscopy Gastroenterology

Herbal Drug Rivals PPIs in Breakthrough Clinical Trial

Herbal Drug Rivals PPIs in Breakthrough Clinical Trial – MM1307

Results from a breakthrough clinical trial investigating the efficacy and tolerability of treatments for functional dyspepsia (FD) have revealed that the natural medicine Iberogast worked as well as a proton pump inhibitor (esomeprazole), with less chance of symptoms recurring after stopping treatment.

Modern Medicine – July 2013

July 11, 2013 by Gastroenterology
Verified by ExactMetrics